Resolve Therapeutics Inks $5.8M
Resolve Therapeutics has raised $5.8 million in a Series B round. Return backer New Science Ventures led the round, with participation from new investor WRF Capital and previous investor Easton Capital. Resolve Therapeutics is based in Seattle.
1 November 2012•3 mins read
